JBF Capital’s Kyntra Bio KYNB Stock Holding History

JBF Capital’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-564	Closed	-$857K	–	103
2018 Q3	$857K	Hold	564	–	–	0.13%	31
2018 Q2	$883K	Buy	564 +200	+55%	+$261K	0.13%	44
2018 Q1	$420K	Buy	+364	New	+$479K	0.07%	57

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

JBF Capital's KYNB Position: Q4 2018 in Review

JBF Capital sold out of Kyntra Bio (KYNB) in Q4 2018, closing a stake of 564 shares — an estimated $857K sold.

JBF Capital first reported a position in KYNB in Q1 2018 and held it in 3 quarters. The position peaked at $883K in Q2 2018. 201 funds tracked by Wall St. Rank hold KYNB as of Q4 2018.

JBF Capital reported no remaining Kyntra Bio position as of Q4 2018 after selling out during the quarter.
JBF Capital sold 564 Kyntra Bio shares in Q4 2018, an estimated $857K.
JBF Capital first reported a position in Kyntra Bio in Q1 2018 and held it in 3 quarters.
JBF Capital's Kyntra Bio position peaked at $883K in Q2 2018.
201 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2018.

Based on JBF Capital's 13F filing for Q4 2018, filed 12 Feb 2019.